ES2136628T3 - 4-iminoquinolinas, procedimiento para su preparacion y su empleo. - Google Patents

4-iminoquinolinas, procedimiento para su preparacion y su empleo.

Info

Publication number
ES2136628T3
ES2136628T3 ES93109965T ES93109965T ES2136628T3 ES 2136628 T3 ES2136628 T3 ES 2136628T3 ES 93109965 T ES93109965 T ES 93109965T ES 93109965 T ES93109965 T ES 93109965T ES 2136628 T3 ES2136628 T3 ES 2136628T3
Authority
ES
Spain
Prior art keywords
iminoquinolines
employment
procedure
preparation
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93109965T
Other languages
English (en)
Inventor
Uta-Maria Billhardt-Troughton
Manfred Rosner
Rudolf Bender
Christoph Meichsner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2136628T3 publication Critical patent/ES2136628T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Detergent Compositions (AREA)

Abstract

COMPUESTO DE FORMULA (I) ASI COMO SUS FORMAS TAUTOMERAS DE FORMULA (IA), (IB) O (IC), DISPONEN DE UNA ACTIVIDAD ANTIVIRAL. LOS SUBSTITUYENTES R1-R4, X E Y TIENEN UN SIGNIFICADO MENCIONADO.
ES93109965T 1992-06-27 1993-06-22 4-iminoquinolinas, procedimiento para su preparacion y su empleo. Expired - Lifetime ES2136628T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221210 1992-06-27

Publications (1)

Publication Number Publication Date
ES2136628T3 true ES2136628T3 (es) 1999-12-01

Family

ID=6462017

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93109965T Expired - Lifetime ES2136628T3 (es) 1992-06-27 1993-06-22 4-iminoquinolinas, procedimiento para su preparacion y su empleo.

Country Status (19)

Country Link
US (1) US5602146A (es)
EP (1) EP0579968B1 (es)
JP (1) JP3605123B2 (es)
KR (1) KR940005577A (es)
CN (1) CN1083477A (es)
AT (1) ATE184003T1 (es)
AU (1) AU670435B2 (es)
CA (1) CA2099213C (es)
DE (1) DE59309756D1 (es)
DK (1) DK0579968T3 (es)
ES (1) ES2136628T3 (es)
GR (1) GR3031853T3 (es)
HU (1) HUT70040A (es)
IL (1) IL106147A (es)
MX (1) MX9303843A (es)
NZ (1) NZ247993A (es)
PH (1) PH31682A (es)
TW (1) TW304945B (es)
ZA (1) ZA934576B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344452A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4428932A1 (de) * 1994-08-16 1996-02-22 Hoechst Ag Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19613591A1 (de) * 1996-04-04 1997-10-09 Hoechst Ag Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
US20040157804A1 (en) * 2002-10-16 2004-08-12 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
JP2007532665A (ja) * 2004-04-14 2007-11-15 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖインテグラーゼ阻害剤化合物のホスホネート類似物
US20110123929A1 (en) * 2007-01-23 2011-05-26 Fujifilm Corporation Oxime compound, photosensitive composition, color filter, production method for the color filter, and liquid crystal display element
JP5305704B2 (ja) * 2008-03-24 2013-10-02 富士フイルム株式会社 新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
JP6483382B2 (ja) * 2014-09-16 2019-03-13 株式会社Adeka 感光性樹脂組成物、その硬化物
JP6734416B2 (ja) * 2019-02-13 2020-08-05 株式会社Adeka 新規化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US758568A (en) * 1903-05-29 1904-04-26 William E Snediker Wrench.
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents
US4985439A (en) * 1985-11-21 1991-01-15 Anheuser-Busch Companies, Inc. Glucose tolerance factor and method of making same
JPH0686379B2 (ja) * 1985-11-21 1994-11-02 アンヒュ−サ−‐ブッシュ・カンパニ−ズ、インコ−ポレイテッド グルコ−ス耐性因子およびその製造方法
US5192768A (en) 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
ES2164639T3 (es) * 1991-04-15 2002-03-01 Aventis Pharma Gmbh Quinoxalinas, procedimiento para su preparacion y su empleo.

Also Published As

Publication number Publication date
IL106147A0 (en) 1993-10-20
EP0579968A1 (de) 1994-01-26
GR3031853T3 (en) 2000-02-29
HUT70040A (en) 1995-09-28
JP3605123B2 (ja) 2004-12-22
DE59309756D1 (de) 1999-10-07
DK0579968T3 (da) 2000-03-27
TW304945B (es) 1997-05-11
KR940005577A (ko) 1994-03-21
CA2099213A1 (en) 1993-12-28
EP0579968B1 (de) 1999-09-01
CN1083477A (zh) 1994-03-09
ATE184003T1 (de) 1999-09-15
AU4149293A (en) 1994-01-06
PH31682A (en) 1999-01-18
NZ247993A (en) 1995-11-27
HU9301875D0 (en) 1993-09-28
CA2099213C (en) 2005-11-29
ZA934576B (en) 1994-01-31
AU670435B2 (en) 1996-07-18
MX9303843A (es) 1994-01-31
US5602146A (en) 1997-02-11
JPH0673012A (ja) 1994-03-15
IL106147A (en) 1997-06-10

Similar Documents

Publication Publication Date Title
ES2141183T3 (es) Utilizacion de disolventes de hidrocarburos halogenados.
ES2122043T3 (es) Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas.
ES2059841T3 (es) Nitro compuestos con actividad insecticida.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2195970T3 (es) L-ribavirina y usos de la misma.
DK0689426T3 (da) Terapeutisk middel til behandling af melanomer
ES2092585T3 (es) Polioxazolidinas con grupos carbonato, procedimiento para su preparacion y su empleo.
ES2060415T3 (es) 1,3-bis(3-(mono- o poli-hidroxi)acilamino-5-(mono- o polihidroxialquil)aminocarbonil-2,4,6-triyodo-benzoilamino)hidroxi- o hidroxialquil-propanos, procedimiento para su preparacion y medios de contraste para rayos x que los contienen.
ES2136628T3 (es) 4-iminoquinolinas, procedimiento para su preparacion y su empleo.
ES2163538T3 (es) Derivados de 3-oxo y 3-tioxo-4-aza-androstano diastereomericamente puros y su uso como antiandrogenos.
ES2042556T3 (es) N,n'-diacilhidrazinas n-sustituidas, n'-sustituidas insecticidas.
ES2014392A4 (es) Procedimiento para la fabricacion de peroxido de hidrogeno.
DK162269C (da) Fremgangsmaade til fremstilling af fotopolymeriserede relieftrykforme med klaebefrie, glatte overflader til flexotryk
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
FI872833A0 (fi) Anordning foer att aostadkomma lokalt verkande tryckkrafter pao en glasskiva innanfoer konturerna foer den bilglasskiva som utskaers.
ES2052850T3 (es) Un procedimiento para preparar un compuesto de hidrazona.
ES2179857T3 (es) Derivados de quinoleina sustituidos, procedimiento para su preparacion y su utilizacion.
ES2003063A4 (es) Derivados de pirrolidin-2-ona, que tengan actividad nootropica.
ES2029799T3 (es) Derivados de 2,5,6,7 tetranor-4,8-inter-m-fenilen pg12.
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
ES2105425T3 (es) Composiciones, formadas por polimeros electroconductores y poliuretanos.
DE3674971D1 (en) P-acylaminobenzamide.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 579968

Country of ref document: ES